Cleveland Clinic Research links tumor bacteria to immunotherapy resistance in head and neck cancer

Two studies find that elevated bacteria levels in tumors weaken immune response, paving way for new therapeutic strategies

2026-01-02

(Press-News.org) Cleveland: Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others.

Two new studies, published simultaneously in Nature Cancer, reveal that elevated levels of bacteria in the tumor microenvironment suppress immune response, driving resistance to immunotherapy in patients with head and neck squamous cell carcinoma.

“These studies shift the focus of immunotherapy resistance research beyond tumor genetics to unexpected factors like the tumor microbiome,” said Timothy Chan, M.D., Ph.D., chair of Cleveland Clinic’s Department of Cancer Sciences and lead author of one of the papers. “By identifying bacteria as a key barrier to treatment, we’re opening the door to new strategies for patient selection and targeted antibiotic therapies, potentially improving outcomes for those who don’t benefit from immunotherapy.”

The research team, led by Dr. Chan, Daniel McGrail, Ph.D., assistant staff in the Center for Immunotherapy & Precision Immuno-Oncology, and Natalie Silver, M.D. M.S., director of Head and Neck Cancer Research, validated the findings through patient samples, preclinical models and clinical trial data.

In the first paper, Dr. McGrail analyzed genetic data from patient tumor samples, revealing that higher bacterial levels – not specific strains – weaken immune response. Dr. Silver confirmed these findings in preclinical models: antibiotics reduced tumor size and improved immune response, while adding bacteria made tumors resistant to immunotherapy. The team also worked with Renata Ferrarotto, M.D., from the University of Texas MD Anderson Cancer Center to study the relationship between bacteria and treatment responses in head and neck cancer patient clinical trial samples.

“Immunotherapy is a promising treatment option for patients with head and neck cancer, but the majority unfortunately do not respond,” Dr. Silver said. “Our research examines how bacteria influence treatment failure. This can help us identify patients most likely to benefit from immunotherapy, with the goal of avoiding unnecessary risk and exposure. Ultimately, we aim to develop targeted interventions that restore the effectiveness of immunotherapy in for patients who do not initially respond.”

In the second paper, Dr. Chan led a data analysis of the Javelin HN100 Phase III clinical trial, which tested whether adding anti-PDL1 immunotherapy to standard chemoradiotherapy improved outcomes for patients with head and neck squamous cell carcinoma. The analysis confirmed that patients with high tumor bacteria levels had poorer outcomes with immunotherapy compared to standard chemoradiotherapy. The trial included collaborators from Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute.

Together, the two studies showed that elevated bacteria levels in tumors attract neutrophils, white blood cells that fight infection. While neutrophils are essential for combating bacterial infections, in cancer they can suppress the immune system needed for immunotherapy to work effectively. These findings lay the foundation for future research on why bacteria are attracted to tumors and how to modify them to improve treatment.

Building on these discoveries, Dr. Silver launched a clinical trial funded by the American Cancer Society and VeloSano, a Cleveland Clinic fund-raising movement to beat cancer, to test whether antibiotics can lower tumor microbiome levels and boost immunotherapy response in patients with head and neck squamous cell carcinoma. Meanwhile, Dr. McGrail is studying how bacteria influence cancer development and why some tumors harbor more bacteria, aiming to develop new therapeutic strategies, and Dr. Chan is exploring how bacteria may induce DNA mutations in tumors.

“By uncovering the tumor microbiome’s role in immunotherapy resistance, these studies mark a significant step forward in understanding the complex interactions between cancer and the immune system,” said Dr. McGrail. “This research broadens our perspective on cancer treatment and paves the way for developing personalized therapies to improve outcomes for patients.”

END

ELSE PRESS RELEASES FROM THIS DATE:

First Editorial of 2026: Resisting AI slop

2026-01-01

The first Editorial of the year at Science always gives the Editor-in-Chief an opportunity to reflect on notable developments for the Science journals. In this Editorial, Holden Thorp focuses on AI, discussing how it “will allow the scientific community to do more if it picks the right ways to use it.” He revisits the journals’ policies and approaches related to AI. The journals do use select AI tools. Over the past year for example, Science has collaborated with DataSeer to evaluate adherence to its policy mandating the sharing of underlying data and code for all published ...

Joint ground- and space-based observations reveal Saturn-mass rogue planet

2026-01-01

Simultaneous ground- and space-based observations of a newly discovered free-floating planet have enabled direct measurement of its mass and distance from Earth, according to a new study. The findings offer insights into the diverse and dynamic pathways by which planets can be cast adrift into interstellar space. Although studies to date have only revealed a handful of such free-floating planets, detections are expected to increase in the coming years, particularly with the NASA Nancy Grace Roman Space Telescope campaign that is scheduled for launch in 2027, ...

Inheritable genetic variant offers protection against blood cancer risk and progression

2026-01-01

A newly identified and rare genetic variant slows the growth of mutated blood stem cells, researchers report, and it reduces the risk of leukemia. The findings offer insight into why some people are naturally more resistant to clonal expansion and age-related blood cancers despite acquiring risky mutations. As tissues age, they quietly accumulate many mutations that can drive cancer. In the blood-forming, or hematopoietic, system, such mutations often appear in otherwise healthy individuals as clonal hematopoiesis (CH), a process in which certain blood stem cell (HSC) ...

Pigs settled Pacific islands alongside early human voyagers

2026-01-01

Pigs across the Pacific can trace their ancestry to Southeast Asian domestic pigs that accompanied early Austronesian-speaking groups as they island-hopped across the region, according to a new genomic study. For thousands of years, humans have moved animals far beyond their natural ranges – sometimes accidentally and sometimes deliberately, but often with profound ecological consequences, especially on islands. Pigs are a striking example; although their home ranges lie mostly west of the Wallace Line, multiple species are now widespread across the islands of Southeast Asia and throughout Oceania. Archaeological and genetic evidence suggest that pigs ...

A Coral reef’s daily pulse reshapes microbes in surrounding waters

2026-01-01

A new study shows that coral reefs don’t just provide a home for ocean life, they also help set the daily “schedule” for tiny microbes living in the water nearby. Over the course of a single day, the quantity and types of microbes present can shift dramatically. To see this in detail, researchers took frequent water samples and used a mix of genetic and ecological methods and tools, as well as advanced imaging techniques, to track what was happening hour by hour. They found that reefs can shape microbial communities ...

EAST Tokamak experiments exceed plasma density limit, offering new approach to fusion ignition

2026-01-01

Researchers working on China's fully superconducting Experimental Advanced Superconducting Tokamak (EAST) have experimentally accessed a theorized "density-free regime" for fusion plasmas, achieving stable operation at densities well beyond conventional limits. The results, reported in Science Advances on January 1, provide new insights into overcoming one of the most persistent physical obstacles on the path toward nuclear fusion ignition. The study was co-led by Prof. ZHU Ping from Huazhong University of Science and Technology and Associate Prof. YAN Ning from the Hefei Institutes of Physical Science ...

Groundbreaking discovery reveals Africa’s oldest cremation pyre and complex ritual practices

2026-01-01

About 9,500 years ago, a community of hunter-gatherers in central Africa cremated a small woman on an open pyre at the base of Mount Hora, a prominent natural landmark in northern Malawi, according to a new study coauthored by an international team based in the United States, Africa, and Europe. It is the first time this behavior has been documented in the African hunter-gatherer record. The study, published in the journal Science Advances, provides the earliest evidence of intentional cremation in Africa and describes ...

First breathing ‘lung-on-chip’ developed using genetically identical cells

2026-01-01

Researchers at the Francis Crick Institute and AlveoliX have developed the first human ‘lung-on-chip’ model using stem cells taken from only one person. These chips simulate breathing motions and lung disease in an individual, holding promise for testing treatments for infections like tuberculosis (TB) and delivering personalised medicine. Air sacs in the lungs called alveoli are the essential site of gas exchange and also an important barrier against inhaled viruses and bacteria that cause respiratory diseases like flu or TB. Researchers have been working to recreate the battle between human cells and bacteria in the ...

How people moved pigs across the Pacific

2026-01-01

How people moved pigs across the Pacific Genomic study reveals the routes taken by people as they island hopped across Indonesia A new study, published today in the journal Science, reveals how millennia of human migration across Pacific islands led to the introduction of invasive pig species all over the Asia-Pacific region. The study was led by Laurent Frantz, Professor of Palaeogenomics at Queen Mary University of London (QMUL), and the Ludwig Maximilians University of Munich (LMU), David Stanton, from Cardiff University, and Greger Larson, from the University of Oxford. Plants and animals have not always spread ...

Interaction of climate change and human activity and its impact on plant diversity in Qinghai-Tibet plateau

2025-12-31

The Qinghai-Tibet plateau (QTP) is the largest and highest plateau in the world, and is an important center for biodiversity that houses an array of high-elevation ecosystems. Despite its importance, QTP has faced multiple conservation challenges over the past decades, in particular due to climate changes (e.g. rising temperature, changing precipitation patterns, and an increase in extreme weather) and over exploitation of natural resources by human activities. Despite growing evidence that plant diversity on QTP ...